Examlex
Zeracizumab is an experimental angiogenesis inhibitor targeting vascular endothelial growth factor that is being tested for the treatment of advanced, chemotherapy-naive, non-squamous non-small cell lung cancer (NSCLC) . Part of the drug company's evaluation process is to analyze the 1-year survival after treatment to determine the clinical efficacy of the experimental treatment. The results are given in the table below. Which of the following best represents the number needed to harm for the zeracizumab-containing regimen?
Regret Aversion
A psychological effect where individuals avoid making decisions that could result in action-based regret, affecting investment choices and risk-taking behaviors.
Short-Term Losses
Financial losses realized on the sale or exchange of an asset held for one year or less.
Making a Decision
The cognitive process of selecting a course of action from among multiple alternatives.
Q5: A 12-year-old boy is evaluated in the
Q11: A 54-year-old man comes to the office
Q33: A 32-year-old woman, gravida 2 para 1,
Q39: A 66-year-old woman comes to the clinic
Q93: A meta-analysis of several trials on the
Q97: A 67-year-old man comes to the office
Q104: A study is designed to evaluate the
Q109: A 54-year-old man comes to the office
Q126: A 24-year-old woman comes to the office
Q199: A 26-year-old previously healthy man comes to